Sarcopenia and cardiovascular disease in patients with and without kidney disease: what do we know?
Int Urol Nephrol
; 55(5): 1161-1171, 2023 May.
Article
en En
| MEDLINE
| ID: mdl-36327007
Cardiovascular disease (CVD) incidence is high in patients with chronic kidney disease (CKD) and is the most frequent cause of mortality in this population. Advanced age, hypertension, uremic toxins, endothelial dysfunction, atherosclerosis, hyperhomocysteinemia, oxidative stress, and inflammation are among the leading causes of increased CVD in advanced stages of CKD. Although defined as a decrease in muscle strength associated with aging, sarcopenia is also prevalent in CKD patients. Sarcopenia causes physical disability, low quality of life, and mortality. Regular exercise and nutritional supplementation may slow the progression of sarcopenia. Recent studies have shown that sarcopenia increases the risk of CVD and mortality in people with or without kidney disease. This review discusses the relationship between sarcopenia and CVD in light of the current literature.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
Insuficiencia Renal Crónica
/
Sarcopenia
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
En
Revista:
Int Urol Nephrol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Turquía
Pais de publicación:
Países Bajos